Tumor dormancy: Is adaptative immunity a key player?;«Je te tiens, tu me tiens»... Dormance tumorale: Un équilibre instable?

Medecine/Sciences

Volumn 24, Issue 6-7, 2008, Pages 575-576

  Quesnel, Bruno ^a,b  

^a Institut de Recherche sur le Cancer de Lille   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; CARCINOGENESIS; HUMAN; NOTE; TUMOR IMMUNITY; ARTICLE; DISEASE COURSE; IMMUNITY; IMMUNOLOGY; NEOPLASM; PATHOPHYSIOLOGY;

DISEASE PROGRESSION; HUMANS; IMMUNITY; NEOPLASMS;

EID: 47749134193     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/20082467575     Document Type: Note

References (12)

1. Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 2007 ; 7 : 834-46.
2. Meng S, Tripathy D, Frenkel EP, et al. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 2004 ; 10 : 8152-62.
3. Quesnel B. Cancer vaccines and tumor dormancy: a long-term struggle between host antitumor immunity and persistent cancer cells? Expert Rev Vaccines 2006 ; 5 : 773-81.
4. Vitetta ES, Tucker TF, Racila E, et al. Tumor dormancy and cell signaling. V. Regrowth of the BCL1 tumor after dormancy is established. Blood 1997 ; 89 : 4425-36.
5. Saudemont A, Hamrouni A, Marchetti P, et al. Dormant tumor cells develop cross-resistance to apoptosis induced by CTLs or imatinib mesylate via methylation of suppressor of cytokine signaling 1. Cancer Res 2007 ; 67 : 4491-8.
6. Saudemont A, Jouy N, Hetuin D, Quesnel B. NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells. Blood 2005 ; 105 : 2428-35.
7. Saudemont A, Quesnel B. In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis. Blood 2004 ; 104 : 2124-33.
8. Schardt JA, Meyer M, Hartmann CH, et al. Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. Cancer Cell 2005 ; 8 : 227-39.
9. Koebel CM, Vermi W, Swann JB, et al. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 2007 ; 450 : 903-7.
10. Melief CJ. Cancer: immune pact with the enemy. Nature 2007 ; 450 : 803-4.
11. Chouaib S, El Hage F, Benlalam H, Mami-Chouaib F. Immunothérapie du cancer : espoirs et réalités. Med Sci (Paris) 2006 ; 22 : 755-9.
12. Ghiringhelli F, Zitvogel L. Stratégies vaccinales contre le mélanome. Med Sci (Paris) 2006 ; 22 : 183-7.